Reading OPK? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track OPK free→Reading OPK? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track OPK free→QuarterlyIQ Insights · OPK
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition. On April 28, 2026, OPKO Health, Inc. (the “Company”) issued a press release announcing operating and financial highlights for the quarter ended March 31, 2026. The press release also contains information on how to access the conference call the Company is hosting to provide a business update and discuss its financial and operating results for the first quarter ended March 31, 2026, as well as provide financial guidance. A copy of the press releas…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 18, 2026, the Board of Directors of OPKO Health, Inc. (the “Company”), appointed Subbarao V. Uppaluri, Ph.D. as a new director with immediate effect to serve until the Company’s 2026 Annual Meeting of Stockholders and until his successor shall be duly elected or appointed or his earlier death or resignation. Dr. Uppaluri is expected to be…
Results of Operations and Financial Condition. On February 26, 2026, OPKO Health, Inc. (the “Company”) issued a press release announcing operating and financial highlights for the quarter and year ended December 31, 2025. The press release also contains information on how to access the conference call the Company is hosting to discuss its financial and operating results for the fourth quarter and year ended December 31, 2025, as well as provide business updates and financial guidance. A copy…
Results of Operations and Financial Condition. On October 29, 2025, OPKO Health, Inc. (the “Company”) issued a press release announcing operating and financial highlights for the quarter ended September 30, 2025. The press release also contains information on how to access the conference call the Company is hosting to provide a business update and discuss its financial and operating results for the third quarter ended September 30, 2025, as well as provide financial guidance. A copy of the pr…
Results of Operations and Financial Condition. On July 31, 2025, OPKO Health, Inc. (the “Company”) issued a press release announcing operating and financial highlights for the quarter ended June 30, 2025. The press release also contains information on how to access the conference call the Company is hosting to provide a business update and discuss its financial and operating results for the second quarter ended June 30, 2025, as well as provide financial guidance. A copy of the press release…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 27, 2025, the Compensation Committee of the Board of Directors (the “ Committee ”) of OPKO Health, Inc. (the “ Company ”) held a meeting to review certain compensation matters for the Company’s executive officers and non-executive employees. At the meeting, the Committee (i) granted stock options to the Company’s named executive officers (th…
Results of Operations and Financial Condition. On April 30, 2025, OPKO Health, Inc. (the “Company”) issued a press release announcing operating and financial highlights for the quarter ended March 31, 2025. The press release also contains information on how to access the conference call the Company is hosting to provide a business update and discuss its financial and operating results for the first quarter ended March 31, 2025, as well as provide financial guidance. A copy of the press releas…
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OPKO Health, Inc. By: /s/ Steven D. Rubin Date: April 1, 2025 Name: Steven D. Rubin Title: Executive Vice President-Administration
Entry into a Material Definitive Agreement. As previously reported, on March 27, 2025, OPKO Health, Inc., a Delaware corporation (the “ Company ”), entered into exchange agreements (the “ Exchange Agreements ” and each an “ Exchange Agreement ”) with certain institutional holders (the “ Noteholders ”) of the Company’s outstanding 3.75% Convertible Senior Notes due 2029 (the “ Notes ”), pursuant to which the Noteholders agreed to exchange $152,471,000 aggregate principal amount of Notes for an…
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OPKO Health, Inc. By: /s/ Steven D. Rubin Date: March 28, 2025 Name: Steven D. Rubin Title: Executive Vice President-Administration
Entry into a Material Definitive Agreement. On March 27, 2025, OPKO Health, Inc., a Delaware corporation (the “ Company ”), entered into exchange agreements (the “ Exchange Agreements ” and each an “ Exchange Agreement ”) with certain institutional holders (the “ Noteholders ”) of the Company’s outstanding 3.75% Convertible Senior Notes due 2029 (the “ Notes ”), pursuant to which the Noteholders have agreed to exchange (the “ Exchange ”) $152,471,000 aggregate principal amount of Notes (the “…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.